Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Notes underwriting agrmnt

Denali Capital Acquisition Corp. Create: Alert

All | News | Filings
Date FiledTypeDescription
10/11/2023 425 Form 425 - Prospectuses and communications, business combinations:
10/11/2023 8-K Quarterly results
08/15/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/14/2023 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
08/04/2023 425 Form 425 - Prospectuses and communications, business combinations:
08/04/2023 425 Form 425 - Prospectuses and communications, business combinations:
08/04/2023 8-K Investor presentation
Docs: "INVESTOR PRESENTATION DATED AUGUST 2023"
07/13/2023 425 Form 425 - Prospectuses and communications, business combinations:
07/13/2023 8-K Entered into an underwriting agreement for the issuance and sale of notes
Docs: "CONVERTIBLE PROMISSORY NOTE",
"Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete an Initial Business Combination"
05/16/2023 SC 13G Denali Capital Global Investments LLC reports a 22.8% stake in Denali Capital Acquisition Corp.
05/15/2023 10-Q Quarterly Report for the period ended March 31, 2023
03/17/2023 10-K Annual Report for the period ended December 31, 2022
02/14/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/14/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/10/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/10/2023 SC 13G BOOTHBAY FUND MANAGEMENT, LLC reports a 5.4% stake in Denali Capital Acquisition Corp.
02/07/2023 SC 13G Hudson Bay Capital Management LP reports a 5.7% stake in Denali Capital Acquisition Corp.
01/31/2023 SC 13G/A Feis Lawrence reports a 2.9% stake in Denali Capital Acquisition Corp.
01/26/2023 425 Form 425 - Prospectuses and communications, business combinations:
01/26/2023 8-K/A Investor presentation
Docs: "COMPANY VOTING AND SUPPORT AGREEMENT This COMPANY VOTING AND SUPPORT AGREEMENT is entered into as of January 25, 2023, by and between Longevity Biomedical, Inc., a Delaware corporation , Denali Capital Acquisition Corp., a Cayman Islands exempted company with limited liability , Denali SPAC Holdco, Inc., a Delaware Corporation , and the securityholder of the Company set forth on Schedule I hereto . The Company, Purchaser and the Securityholder are sometimes referred to herein as a “ Party ” and collectively as the “ Parties ”. WITNESSETH : WHEREAS, as of the date hereof, the Securityholder is the holder of record and “ beneficially owns ” and is entitled to dispose of and to vote the number of shares of Company Common Stock set forth opposite its name on Schedule I hereto , are collectivel...",
"VOTING AND SUPPORT AGREEMENT This VOTING AND SUPPORT AGREEMENT is entered into as of January 25, 2023, by and between Longevity Biomedical, Inc., a Delaware corporation , Denali Capital Acquisition Corp., a Cayman Islands exempted company with limited liability , and Denali Capital Global Investment LLC, a Cayman Islands limited liability company . The Company and the Sponsor are sometimes referred to herein as a “ Party ” and collectively as the “ Parties ”. WITNESSETH : WHEREAS, as of the date hereof, the Sponsor “ beneficially owns ” and is entitled to dispose of and to vote the number of Class B ordinary shares, par value $0.0001 per share , of the Purchaser set forth opposite its name on Schedule I hereto , are collectively referred to herein as the “ Subject Shares ”); WHEREAS, the C...",
"INVESTMENT IN ANY SECURITIES DESCRIBED HEREIN HAS NOT BEEN APPROVED OR DISAPPROVED BY THE SEC OR ANY OTHER REGULATORY AUTHORI TY NOR HAS ANY AUTHORITY PASSED UPON OR ENDORSED THE MERITS OF THE POTENTIAL BUSINESS COMBINATION OR THE ACCURACY OR ADEQUACY OF THE INFORMATION CONTAINED HE REI N. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE. PROSPECTIVE INVESTORS MUST RELY SOLELY ON THEIR OWN EXAMINATION OF A POTENTIAL INVESTMENT IN THE COMPANY OR THE SPAC AND THE TER MS OF THE DEFINITIVE DOCUMENTATION, INCLUDING THE MERITS AND RISKS INVOLVED, AND NOT ON ANY INFORMATION OR REPRESENTATION MADE OR ALLEGED TO HAVE BEE N MADE HEREIN OR OTHERWISE."
01/26/2023 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits  Inte...
Docs: "Longevity Biomedical, Inc. and Denali Capital Acquisition Corp. Announce Business Combination to Create Nasdaq-Listed Biopharmaceutical Company Focused on Advancing New Technologies to Promote Human Health and Longevity"
11/15/2022 10-Q Quarterly Report for the period ended September 30, 2022
10/20/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
10/19/2022 8-K Quarterly results
08/12/2022 10-Q Quarterly Report for the period ended June 30, 2022
05/27/2022 8-K Quarterly results
05/23/2022 10-Q Quarterly Report for the period ended March 31, 2022
04/15/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "DENALI CAPITAL ACQUISITION CORP. INDEX TO FINANCIAL STATEMENT Page Audited Financial Statement of Denali Capital Acquisition Corp.: Report of Independent Registered Public Accounting Firm F-2 Balance Sheet as of April 11, 2022 F-3 Notes to Financial Statement F-4"
04/12/2022 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Departure of Directors or Certain Office...
Docs: "Denali Capital Acquisition Corp. UNDERWRITING AGREEMENT April 6, 2022 Denali Capital Acquisition Corp. 437 Madison Avenue, 27th Floor New York, New York 10022 US Tiger Securities, Inc. EF Hutton, division of Benchmark Investments, LLC As Representatives of the Underwriters named on Schedule A hereto",
"THE COMPANIES ACT OF THE CAYMAN ISLANDS COMPANY LIMITED BY SHARES AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION OF Denali Capital Acquisition Corp. THE COMPANIES ACT OF THE CAYMAN ISLANDS COMPANY LIMITED BY SHARES AMENDED AND RESTATED MEMORANDUM OF ASSOCIATION OF Denali Capital Acquisition Corp. 1 The name of the Company is Denali Capital Acquisition Corp.. 2 The Registered Office of the Company shall be at the offices of Maples Corporate Services Limited, PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands, or at such other place within the Cayman Islands as the Directors may decide. 3 The objects for which the Company is established are unrestricted and the Company shall have full power and authority to carry out any object not prohibited by the laws of the Cay...",
"WARRANT AGREEMENT DENALI CAPITAL ACQUISITION CORP. and VSTOCK TRANSFER, LLC Dated April 6, 2022",
"INVESTMENT MANAGEMENT TRUST AGREEMENT",
"Registration and Shareholder Rights Agreement",
"PRIVATE PLACEMENT UNITS PURCHASE AGREEMENT",
"FORM OF Indemnity Agreement",
"Denali Capital Acquisition Corp. Announces Pricing of $75 Million Initial Public Offering NEW YORK, April 6, 2022 /PRNewswire/ — Denali Capital Acquisition Corp. announced today that it priced its initial public offering of 7,500,000 units at a price of $10.00 per unit. The units have been approved for listing on The NASDAQ Global Market and trade under the symbol "DECAU" beginning on April 7, 2022. Each unit issued in the IPO consists of one share of Class A ordinary share and one redeemable warrant, with each whole warrant exercisable to purchase one whole share of Class A ordinary share at a price of $11.50 per share. After the securities comprising the units begin separate trading, Class A ordinary shares and warrants are expected to be listed on NASDAQ under the symbols "DECA" and "DE..."
04/07/2022 EFFECT Form EFFECT - Notice of Effectiveness:
04/06/2022 CERT Form CERT - Certification by an exchange approving securities for listing:
04/06/2022 8-A12B Form 8-A12B - Registration of securities [Section 12(b)]:
03/25/2022 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy